Emerging Therapeutic Targets for Male Germ Cell Tumors

Area of Science:

• Oncology
• Cancer Research
• Translational Medicine

Background:

• Male germ cell tumors (GCTs) are highly curable cancers.
• 10-15% of metastatic GCT patients do not respond to first-line cisplatin-based chemotherapy.
• Limited progress in GCT management and treatment options over recent decades.

Purpose of the Study:

• To review emerging molecular targets for male GCT.
• To highlight novel therapeutic agents for metastatic GCT.
• To propose strategies for future clinical trials in male GCT.

Main Methods:

• Literature review of recent clinical trials and translational research in male GCT.
• Analysis of molecular alterations and potential therapeutic targets.
• Evaluation of ongoing and completed phase I/II studies.

Main Results:

• Few advancements in male GCT treatment despite progress in other cancers.
• Need for better understanding of molecular drivers of GCT.
• Lack of identified predictive molecular profiles for treatment response.

Conclusions:

• Emerging targets and therapies show promise for metastatic male GCT.
• Translational research is crucial for identifying predictive biomarkers.
• Future clinical trials should incorporate molecular profiling to guide treatment strategies.